Significance and regulation of gastric secretion of platelet-activating factor (PAF-acether) in man. 1992

I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
Service d'Hépato-Gastroentérologie, CHU Bichat, Paris, France.

Platelet-activating factor (PAF) has been implicated in the pathogenesis of acute inflammatory and ulcerative diseases of the upper gastrointestinal tract. In the present study, we compared the gastric output of PAF and its precursors with gastric acid output, in patients with various upper gastrointestinal tract diseases and healthy controls. PAF and precursors were also extracted from gastric biopsies from subjects with chronic gastritis and/or gastric colonization by Helicobacter pylori. Under basal conditions, hourly gastric PAF output increased in esophagitis and erosive gastritis, but not in duodenal ulcer or Zollinger-Ellison syndrome. In the gastric juice of duodenal ulcer patients, PAF output rose after secretin, but in patients with Zollinger-Ellison syndrome, PAF was only detected when gastric acid secretion had been reduced by antisecretory drugs and no concurrent changes were observed in serum gastrin levels. After pentagastrin, patients and controls exhibited a significant decrease in PAF output and a negative correlation was found between PAF and acid outputs (r = -0.57, p < 0.01). When PAF was incubated with gastric juice in vitro, it underwent degradation irrespective of the medium pH. We found no relation between the outputs of PAF and precursors and the severity of gastritis or gastric colonization by H. pylori. Overall, these results suggest that PAF might be released in the stomach by gastric epithelial cells and could be responsible for mucosal injury of the upper gastrointestinal tract.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010418 Pentagastrin A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. Acignost,Gastrin Pentapeptide,Peptavlon,Pentapeptide, Gastrin
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005260 Female Females
D005745 Gastric Acidity Determination Gastric analysis for determination of free acid or total acid. Acidity Determination, Gastric,Acidity Determinations, Gastric,Determination, Gastric Acidity,Determinations, Gastric Acidity,Gastric Acidity Determinations
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D005755 Gastrins A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters. Gastrin

Related Publications

I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
December 1982, Agents and actions,
I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
January 1989, Advances in prostaglandin, thromboxane, and leukotriene research,
I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
January 1986, Bulletin europeen de physiopathologie respiratoire,
I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
June 1984, European journal of pharmacology,
I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
December 1981, Agents and actions,
I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
November 1980, British journal of haematology,
I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
January 1988, Progress in clinical and biological research,
I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
January 1981, Biochimie,
I Sobhani, and Y Denizot, and C Vissuzaine, and J Vatier, and J Benveniste, and M J Lewin, and M Mignon
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
Copied contents to your clipboard!